CL-197
CL-197 is an orally active and long-acting purine anti-HIV nucleoside reverse transcriptase inhibitor (NRTI) . CL-197 has potential effect on the research of viral, oncological and cerebrovascular diseases[1]. CL-197 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Product Specifications
CAS Number
1030595-07-3
UNSPSC
12352005
Target
HIV Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/cl-197.html
Purity
99.32
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O[C@H]1[C@H](F)[C@H](N2C=NC3=C(N)N=C(F)N=C32)O[C@@]1(CO)C#C
Molecular Formula
C12H11F2N5O3
Molecular Weight
311.24
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
FITC-Linked Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
FITC-Linked Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
FITC-Linked Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
FITC-Linked Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)